Literature DB >> 27694478

Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.

Lina Zhou1,2, Huifang Dai2, Jian Wu3, Mian Zhou2, Hua Yuan4, Juan Du2, Lu Yang5, Xiwei Wu5, Hong Xu6, Yuejin Hua6, Jian Xu3, Li Zheng7, Binghui Shen8.   

Abstract

Flap endonuclease 1 (FEN1) phosphorylation is proposed to regulate the action of FEN1 in DNA repair as well as Okazaki fragment maturation. However, the biologic significance of FEN1 phosphorylation in response to DNA damage remains unknown. Here, we report an in vivo role for FEN1 phosphorylation, using a mouse line carrying S187A FEN1, which abolishes FEN1 phosphorylation. Although S187A mouse embryonic fibroblast cells showed normal proliferation under low oxygen levels (2%), the mutant cells accumulated oxidative DNA damage, activated DNA damage checkpoints, and showed G1-phase arrest at atmospheric oxygen levels (21%). This suggests an essential role for FEN1 phosphorylation in repairing oxygen-induced DNA damage and maintaining proper cell cycle progression. Consistently, the mutant cardiomyocytes showed G1-phase arrest due to activation of the p53-mediated DNA damage response at the neonatal stage, which reduces the proliferation potential of the cardiomyocytes and impairs heart development. Nearly 50% of newborns with the S187A mutant died in the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dependent switch from glycolysis to fatty acid oxidation. The adult mutant mice developed dilated hearts and showed significantly shorter life spans. Altogether, our results reveal an important role of FEN1 phosphorylation to counteract oxygen-induced stress in the heart during the fetal-to-neonatal transition.-Zhou, L., Dai, H., Wu, J., Zhou, M., Yuan, H., Du, J., Yang, L., Wu, X., Xu, H., Hua, Y., Xu, J., Zheng, L., Shen, B. Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development. © FASEB.

Entities:  

Keywords:  G1-phase arrest; dilated heart; flap endonuclease 1; p53 signaling

Mesh:

Substances:

Year:  2016        PMID: 27694478      PMCID: PMC5161519          DOI: 10.1096/fj.201600631R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  61 in total

Review 1.  DNA repair, genome stability, and aging.

Authors:  David B Lombard; Katrin F Chua; Raul Mostoslavsky; Sonia Franco; Monica Gostissa; Frederick W Alt
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

2.  Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2.

Authors:  D X Tishkoff; A L Boerger; P Bertrand; N Filosi; G M Gaida; M F Kane; R D Kolodner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Regulation of DNA repair throughout the cell cycle.

Authors:  Dana Branzei; Marco Foiani
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02-20       Impact factor: 94.444

4.  Increased oxidative stress in dilated cardiomyopathic heart failure.

Authors:  D Yücel; S Aydoğdu; S Cehreli; G Saydam; H Canatan; M Seneş; B Ciğdem Topkaya; S Nebioğlu
Journal:  Clin Chem       Date:  1998-01       Impact factor: 8.327

5.  Purification and characterization of the DNA polymerase alpha associated exonuclease: the RTH1 gene product.

Authors:  F X Zhu; E E Biswas; S B Biswas
Journal:  Biochemistry       Date:  1997-05-20       Impact factor: 3.162

6.  The role of the peroxisome proliferator-activated receptor alpha (PPAR alpha) in the control of cardiac lipid metabolism.

Authors:  F Djouadi; J M Brandt; C J Weinheimer; T C Leone; F J Gonzalez; D P Kelly
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1999 May-Jun       Impact factor: 4.006

7.  Requirement of the yeast RTH1 5' to 3' exonuclease for the stability of simple repetitive DNA.

Authors:  R E Johnson; G K Kovvali; L Prakash; S Prakash
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

8.  Proliferation failure and gamma radiation sensitivity of Fen1 null mutant mice at the blastocyst stage.

Authors:  Elisabeth Larsen; Christine Gran; Barbro Elisabet Saether; Erling Seeberg; Arne Klungland
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Disruption of the FEN-1/PCNA interaction results in DNA replication defects, pulmonary hypoplasia, pancytopenia, and newborn lethality in mice.

Authors:  Li Zheng; Huifang Dai; Junzhuan Qiu; Qin Huang; Binghui Shen
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

10.  Removal of oxidative DNA damage via FEN1-dependent long-patch base excision repair in human cell mitochondria.

Authors:  Pingfang Liu; Limin Qian; Jung-Suk Sung; Nadja C de Souza-Pinto; Li Zheng; Daniel F Bogenhagen; Vilhelm A Bohr; David M Wilson; Binghui Shen; Bruce Demple
Journal:  Mol Cell Biol       Date:  2008-06-09       Impact factor: 4.272

View more
  3 in total

1.  Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer.

Authors:  Xing Xin; Ti Wen; Li-Bao Gong; Ming-Ming Deng; Ke-Zuo Hou; Lu Xu; Sha Shi; Xiu-Juan Qu; Yun-Peng Liu; Xiao-Fang Che; Yue-E Teng
Journal:  Front Oncol       Date:  2020-04-03       Impact factor: 6.244

2.  San1 deficiency leads to cardiomyopathy due to excessive R-loop-associated DNA damage and cardiomyocyte hypoplasia.

Authors:  Zhiheng Liu; Xu Gao; Zhou Zhou; Sung Wook Kang; Yong Yang; Hao Liu; Chunqin Zhang; Zheng Wen; Xiaoquan Rao; Daowen Wang; Donnell White; Qinglin Yang; Qinqiang Long
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-07-31       Impact factor: 5.187

3.  SUMO-1 modification of FEN1 facilitates its interaction with Rad9-Rad1-Hus1 to counteract DNA replication stress.

Authors:  Xiaoli Xu; Rongyi Shi; Li Zheng; Zhigang Guo; Liangyan Wang; Mian Zhou; Ye Zhao; Bing Tian; Khue Truong; Yuan Chen; Binghui Shen; Yuejin Hua; Hong Xu
Journal:  J Mol Cell Biol       Date:  2018-10-01       Impact factor: 6.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.